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Abstract
Introduction: The objective of this guideline is to outline the role of magnetic resonance imaging (MRI) in clinical decision making
and outcome prediction in patients with traumatic spinal cord injury (SCI).
Methods: A systematic review of the literature was conducted to address key questions related to the use of MRI in patients
with traumatic SCI. This review focused on longitudinal studies that controlled for baseline neurologic status. A
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multidisciplinary Guideline Development Group (GDG) used this information, their clinical expertise, and patient input to
develop recommendations on the use of MRI for SCI patients. Based on GRADE (Grading of Recommendation, Assessment,
Development and Evaluation), a strong recommendation is worded as “we recommend,” whereas a weaker recommendation is
indicated by “we suggest.”
Results: Based on the limited available evidence and the clinical expertise of the GDG, our recommendations were: (1) “We
suggest that MRI be performed in adult patients with acute SCI prior to surgical intervention, when feasible, to facilitate improved
clinical decision-making” (quality of evidence, very low) and (2) “We suggest that MRI should be performed in adult patients in the
acute period following SCI, before or after surgical intervention, to improve prediction of neurologic outcome” (quality of
evidence, low).
Conclusions: These guidelines should be implemented into clinical practice to improve outcomes and prognostication for
patients with SCI.
Keywords
acute spinal cord injury, clinical decision making, clinical guideline, guideline, magnetic resonance imaging, outcome prediction,
spinal cord injury, traumatic spinal cord injury
Summary of Recommendations
We suggest that MRI be performed in adult patients with
acute spinal cord injury prior to surgical intervention,
when feasible, to facilitate improved clinical decision
making.
Quality of Evidence: Very Low
Strength of Recommendation: Weak
We suggest that MRI should be performed in adult
patients in the acute period following SCI, before or
after surgical intervention, to improve prediction of
neurologic outcome.
Quality of Evidence: Low
Strength of Recommendation: Weak
Introduction
Imaging of the spine is an essential part of the initialmanagement
of acute spinal cord injury (SCI).1 Plain X-rays or computed
tomography (CT) of the spine form the basis of standard trauma
protocols and can identify most fractures and ligamentous inju-
ries. These imaging modalities, however, do not visualize the
spinal cord or the surrounding soft tissues. CT myelography is
an invasive procedure where a radio-opaque dye is injected into
the cerebrospinal fluid (via lumbar puncture) to visualize the
spinal cord; this procedure has nontrivial risk related to lumbar
puncture and injection of dye (cerebrospinal fluid leak, hemor-
rhage, infection, injury to neural tissue, reaction to the dye) and
can be cumbersome to perform in a trauma setting.
Magnetic resonance imaging (MRI) is currently the putative
gold standard for imaging the spinal cord and related soft
tissues1-3; however, debate remains about the appropriate use
of MRI in acute SCI as it requires considerable resources to
ensure 24-hour availability and may be dangerous in trauma
patients with respiratory difficulties or hemodynamic instabil-
ity. MRI studies are usually shortened in acute SCI to minimize
risk and typically consist of sagittal and axial T2-weighted
images, and potentially T1-weighted and short-tau inversion
recovery (STIR) sequences. Some surgeons have argued that
MRI is essential in the acute period of SCI prior to surgical
decision-making to (1) determine if there is ongoing spinal
cord compression; (2) identify what structures are responsible
for compression, such as disc herniation, epidural hematoma,
intramedullary hematoma, and preexisting canal stenosis; and
(3) detect ligamentous instability at the level of injury, or at
other spinal levels, that is not apparent on X-ray or CT.2
Furthermore, through the use of MR angiography (MRA),
vertebral artery injury (VAI) or dissection can be identified,
which can also alter initial management. Finally, certain MRI
features such as hemorrhage or degree of compression may
help predict neurological and functional outcomes, which
could be of great value for patients that suffer SCI and their
treating physicians.4-6
This guideline provides evidence-based recommendations
for the use of MRI in clinical decision making and outcome
prediction in acute SCI. Individual studies have variably
defined the term “acute”; for the purpose of this guideline,
we chose to use a relatively broad definition of within 1 week
of injury. The systematic review aimed to determine (1)
whether MRI influenced clinical decision making and, conse-
quently, neurologic, functional, patient-reported and safety
outcomes; and (2) the most important MRI predictors of neu-
rologic and functional outcomes following acute SCI. The ulti-
mate goal of this guideline is to improve outcome and reduce
morbidity in patients with SCI by promoting standardization of
care and encouraging clinicians to make evidence-informed
decisions. An introductory article in this focus issue provides
further background information on SCI and summarizes the
rationale, scope, and specific aspects of care covered by this
guideline. This article is titled “A Clinical Practice Guideline
for the Management of Acute Spinal Cord Injury: Introduction,
Rationale, and Scope.”
These guidelines are intended to be used by emergency
room physicians, critical care specialists, radiologists, neurol-
ogists, and spine surgeons.
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Methods
This guideline was developed under the auspices of AOSpine
North America, AOSpine International, and the American
Association and Congress of Neurological Surgeons. A multi-
disciplinary Guideline Development Group (GDG) was formed
and consisted of clinicians from a broad range of specialties as
well as patient representation. The GDG was solely responsible
for guideline development and was editorially independent
from all funding sources. Members were required to disclose
financial and intellectual conflicts of interest (see Appendix,
Chapter 2, available in the online version of the article). A
guideline development protocol, based on the Conference on
Guideline Standardization (COGS) checklist,7,8 was created to
outline the rationale and scope of the guideline and to direct its
development. Systematic reviews were conducted based on
accepted methodological standards to summarize the evidence
informing the recommendations. Details of specific methods
used for each topic are outlined in the individual reviews
included in this focus issue. Methods outlined by the Grading
of Recommendation, Assessment, Development and Evalua-
tion (GRADE) Working Group were used to assess the overall
quality (strength) of evidence for critical outcomes.9,10 The
GRADE Guideline Development Tool was used to document
the guideline development process, rank the importance of out-
comes, weigh the benefits and harms of various options, and
determine the strength of recommendations.11-14Methodologists
with no financial or intellectual conflicts of interest worked
closely with clinical authors to conduct the systematic reviews
and provided methodological expertise on the guideline devel-
opment process. Guideline development methods are provided
in another article included in this focus issue: “Guidelines for
the Management of Degenerative Cervical Myelopathy and
Acute Spinal Cord Injury: Development Process and
Methodology.”
Clinical Recommendations
Part 1. The Role of Baseline Magnetic Resonance
Imaging in Clinical Decision Making
Population Description: Patients with acute SCI
Key Question: Should baseline MRI be performed to facil-
itate clinical management decisions in adult patients with
acute spinal cord injury?
Recommendation 1: We suggest that MRI be performed in
adult patients with acute spinal cord injury prior to sur-
gical intervention, when feasible, to facilitate improved
clinical decision making.
Quality of Evidence: Very Low
Strength of Recommendation: Weak
Evidence Summary
A systematic review of the literature was conducted to address
the following key questions: In adult patients with acute trau-
matic SCI, (1) How does the acquisition of a baseline MRI
influence management strategies compared with no MRI (or
another comparator), and consequently, what changes does it
effect in neurologic, functional, patient-reported, and safety
outcomes? (2) Do spinal cord lesion characteristics, pattern,
and length identified on baseline MRI predict neurologic, func-
tional, patient-reported, and safety outcomes? (3) Do spinal
cord characteristics identified on diffusion tensor imaging pre-
dict neurologic, functional, patient-reported, and safety out-
comes? (4) Is there evidence to suggest that baseline MRI is
cost-effective in patients with acute SCI. The systematic
review is published separately as part of this focus issue and
focused on longitudinal studies that adjusted for baseline neu-
rological status and other potential confounding factors.
The systematic review identified a single prospective study
by Papadopoulos et al (2002) that evaluated the effect of pre-
treatment MRI on neurological outcomes.15 A MRI-treatment
protocol was applied to 66/91 patients and led to emergency
surgery in 34 patients (54%). Outcomes in this group were
compared to a reference group of 25 patients that had contra-
indications to MRI, required a non-spinal emergency proce-
dure, or had a “specific surgeon bias regarding the futility of
emergent treatment.” Patients in the MRI-protocol group
improved, on average, an additional 7/10 of a Frankel grade
compared to the reference group (P < .006). Furthermore, 50%
of patients in the MRI-protocol group exhibited an improve-
ment in Frankel grade, whereas only 24% of the reference
group changed grades. Finally, 8 MRI-protocol patients
(12%) improved from a motor-complete injury to independent
ambulation, whereas none of the patients in the reference group
achieved this improvement. Unfortunately, this study did not
specifically evaluate the impact of baseline MRI on treatment
strategies (surgical rates in the reference group were not
reported and no details of clinical decision making were pro-
vided in the MRI group); however, the authors stated that
“emergency MRI provided an essential tool for the accurate
diagnosis of spinal cord compression and directly influenced
our initial clinical management in the majority of protocol
patients.” Finally, the MRI-protocol group had decreased
length of stay. The overall strength of evidence for the impact
of MRI on clinical decision making was assessed as very low.
Rationale for Recommendation
The outcomes ranked as critical for decision making were
improved neurological and functional outcomes, decreased
length of intensive care unit and hospital stay, and the need for
emergency stabilization. The strength of evidence for findings
related to these outcomes was rated as very low (very low¼ 16;
low ¼ 4). The study by Papadopoulos et al had serious risk of
bias as the control group was selected based on MRI exclusion
criteria or “specific surgeon bias regarding the futility of emer-
gent treatment”15; these differences in patient selection may
explain the differences in neurological outcomes and length
of stay between the MRI-protocol and control groups. Further-
more, this study did not directly report how the acquisition of or
findings on MRI altered management decisions and provided
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limited detail in terms of adverse outcomes (“no patient suf-
fered neurological deterioration during transport to/from MRI
suite”). Finally, it is unclear whether an average improvement
of 0.7 on the Frankel Grade is clinically important as the min-
imal clinically important difference has not been established
for this scale. The findings related to neurological and func-
tional outcomes and length of stay were also imprecise with
unknown consistency.
The GDG also discussed several additional sources of very
low level evidence that examined MRI features that may influ-
ence surgical/medical decision making (based on expert opin-
ion). These features include the presence of ongoing spinal
cord compression, ligamentous injury, disc herniation, and
VAI, all of which are could lead to changes in surgical/medical
management decisions. Several of these factors were summar-
ized in a systematic review by Bozzo et al2; this review was
rated as having poor to moderate quality (AMSTAR rating
5/11) by our methodological team because many of the articles
were case series, the timing of MRI relative to injury and
intervention was variable (or not reported), and the authors did
not fully describe their process of data selection, synthesis or
determining overall quality of evidence. Furthermore, none of
the studies identified in the Bozzo et al review directly com-
pared clinical decision making with and without MRI (or
another imaging modality), nor did they relate the use of MRI
with clinical outcomes. There was general consensus (informal,
no vote was performed) among members of the GDG that the
following clinical entities are important for decision making:
Ongoing Spinal Cord Compression. The review by Bozzo et al
briefly mentioned that ongoing spinal cord compression is a
feature that may alter management.2 The rationale for this is
based on the concept that spinal cord compression causes tissue
ischemia, resulting in damage and cell loss in the spinal cord.
Selden et al stated that the identification of ongoing cord com-
pression resulted in the decision to perform decompressive
surgery with greater urgency and that the identification of ante-
rior or posterior cord compression strongly influenced surgical
approach.16 In recent years, several clinical trials, including
STASCIS,17 have used the presence of ongoing spinal cord
compression on MRI as a key inclusion criterion. STASCIS
also helped establish that, in the context of ongoing spinal cord
compression, timely decompression leads to improved out-
comes, confirming that ongoing cord compression is clinically
important. Thus, based primarily on expert opinion and sup-
ported by indirect evidence, ongoing spinal cord compression
was considered important for clinical decision making,
although the evidence is insufficient.
Ligamentous Injury. Partial or complete injuries to spinal liga-
ments can cause mechanical instability, which is the abnormal
movement of one bone relative to another. The clinical impli-
cation of mechanical instability is that the spinal cord can
suffer additional (possibly repetitive) injury if there is abnor-
mal movement. The sensitivity of MRI to detect ligamentous
injury varies across studies and by the specific sequences used:
anterior longitudinal ligament (ALL), 46% to 71%; disk, 93%;
posterior longitudinal ligament (PLL), 43% to 93%; ligamen-
tum flavum (LF), 67%; interspinous ligament (ISL), 36% to
100%; and supraspinous ligament (SSL), 89%.18-23 Certain
ligamentous injuries may cause significant instability of the
spinal column and require surgical stabilization or external
bracing, whereas other injury patterns suggest the possibility
of mechanical instability. However, even in the latter case, the
knowledge of potential instability could affect decisions on the
extent of surgical stabilization and also the clearance of spinal
precautions (and removal of a rigid collar). Thus, based on
expert opinion and supported by indirect evidence, the detec-
tion of ligamentous injury was considered important for clin-
ical decision making.
Disk Herniation and Injury. Within the studies describing
patients with injuries to the cervical spine in Bozzo et al,2
there was a high rate of disk herniation or injury (36%) on
initial MRI. There is some debate among surgeons as to how
important small or moderate disc herniations are, as many
surgeons are willing to perform a closed reduction maneuver
in acute SCI patients without a prereduction MRI.24 Further-
more, the rate of permanent neurological decline in these
cases is less than 1%.24-26 However, the presence of a large
disc herniation is highly likely to influence the surgeon to
perform anterior surgical decompression instead of, or in
addition to, posterior decompression. Thus, based on expert
opinion and supported by indirect evidence, it was concluded
that the detection of large disc herniation is important for
clinical decision making.
Vertebral Artery Injury. VAI can be detected through the use of
MRA, usually using gadolinium contrast.2 In the Bozzo et al
review, 8 studies included a total of 942 patients considered to
be at high risk of a VAI due to the mechanism of trauma and/
or their bony or spinal cord pathology.2 A unilateral VAI was
found in 140 patients (15%), and bilateral injuries/occlusions
in 7 patients (0.7%). The detection of VAI often leads to the
initiation of immediate antiplatelet or anticoagulation ther-
apy, except in specific circumstances where it is contraindi-
cated (usually due to concomitant injuries such as intracranial
hemorrhage). The evidence supporting the use of antiplatelet
or anticoagulation therapy, however, is low and there are
documented risks of hemorrhage, concluding that no treat-
ment may be comparable to antiplatelet treatment. Further-
more, no studies have directly compared MRA versus CT
angiography (CTA) in the modern era of 64-detector CT,
which may have similar or superior diagnostic accuracy com-
pared with MRA. However, at a minimum it can be said,
based on expert opinion, that the detection of VAI is impor-
tant for clinical decision making and that MRI is currently an
accepted method for detecting VAI.
After consideration of these sources of evidence, the majority
of GDGmembers felt that the certainty of the evidence was very
low. Four members of the GDG felt that the evidence was low;
discussions revealed that this difference was due to the fact that
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several MRI studies in acute SCI with clinically useful informa-
tion were excluded and that our systematic review focus may
have been excessively narrow. Many of the reviewed studies,
however, were primarily excluded because they were not long-
itudinal and/or did not adjust for baseline clinical factors such as
neurologic status. Most of the evidence pertinent to this recom-
mendation was indirect and derived from sources outside the
systematic review, and involved intermediate outcomes (eg,
identification of ongoing cord compression, disc herniation, epi-
dural hematoma, ligamentous injury) that were deemed clini-
cally important by expert opinion. The GDG reaffirmed the
need to comply with the GRADE approach to assess the evi-
dence in a rigorous manner. This process identified critical
knowledge gaps; future studies are needed to better identify how
pretreatment MRI in acute SCI directly alters clinical decision
making and the downstream effects on neurological and func-
tional outcomes.
The GDG agreed that there was no or probably no important
uncertainty about how much key stakeholders value the main
outcomes (important uncertainty or variability ¼ 1; probably
no important uncertainty or variability ¼ 6; no important
uncertainty or variability ¼ 7; no known undesirable outcomes
¼ 8). Clinicians, patients, and payers would likely similarly
value improvement in neurological and functional outcomes
and reduced length of stay.
The anticipated desirable effects were improved clinical
decision making, functional status and neurological outcomes,
decreased hospital stay, and reduced risk of additional SCI. The
GDG agreed that the benefits of MRI to improve immediate
clinical decision making could be profound for certain patients,
especially those with ongoing cord compression, disc hernia-
tion, epidural hematoma, or ligamentous injury. More specifi-
cally, MRI is very effective at identifying the specific
location(s) and cause(s) of ongoing spinal cord compression
that, if present, should be decompressed emergently through
closed reduction or surgery (based on data from STASCIS and
other surgical trials). Cord compression may occur at multiple
levels, from bony fragments, dislocation, intervertebral disc
herniation, epidural hematoma, or other causes; MRI is able
to accurately identify each of these, which allows surgeons to
select an appropriate surgical strategy, including which levels
to decompress and which approach to use (anterior versus pos-
terior versus both). MRI also has moderate to good sensitivity/
specificity for detecting ligamentous injury,2 which can influ-
ence the decision on whether to use surgical instrumentation
and/or external bracing, and also help enable immediate clear-
ance of spinal precautions in patients without injury. MRAmay
also be of value in identifying VAI, which may prompt anti-
platelet or anticoagulation therapy and increased neurological
monitoring of patients. Failure to get an MRI may result in a
surgeon incorrectly ascribing a patient’s poor neurological sta-
tus to the primary injury when, in fact, the patient may have
transient neurological impairment due to cord compression that
may be largely reversible through emergency decompression.
Similarly, missing a ligamentous injury or a VAI could have
catastrophic consequences, due to subsequent traumatic injury
or posterior circulation stroke, respectively. Although the evi-
dence base for these conclusions is severely limited, the GDG
agreed that, based on expert opinion, the anticipated desirable
effects of MRI are probably large (no ¼ 1; probably no ¼ 1;
probably yes ¼1 2; yes ¼ 11).
The anticipated undesirable effects were the risks associated
with obtaining an MRI in the acute phase of SCI. These risks
depend on many factors such as concomitant injuries, neuro-
genic shock, autonomic dysreflexia, and pain, and include (1)
keeping a patient supine for approximately 30 minutes, espe-
cially in critically ill patients with hemodynamic instability or
concomitant head/chest injuries; and (2) delaying the time to
spinal cord decompression. The GDG unanimously agreed
that the undesirable effects of obtaining an MRI are probably
small and that the desirable effects are probably large relative
to the undesirable effects. Clinical judgement, however, is
required to assess whether a patient is able to tolerate MRI.
The GDG unanimously agreed that the resources required to
implement MRI in the setting of acute SCI are not small. MRI
can be very costly and include both capital expenses (approx-
imately US$1-2 million) and operating costs (eg, facilities and
trained technicians). No studies were identified that evaluated
the cost-effectiveness of MRI; however, such a study would
likely require assumptions and methods that may limit its valid-
ity/applicability across centers and countries. In addition, no
studies quantifying the benefits of MRI compared with other
strategies were identified. As a result, the GDG determined that
it is uncertain whether the incremental cost of MRI in an acute
SCI setting is small relative to the net benefits.
Ten members of the GDG agreed that a recommendation for
MRI would probably reduce health inequities if policy makers
fund initiatives to ensure patients with SCI have better access to
MRI (probably reduced ¼ 9; reduced ¼ 1). Eleven individuals
were uncertain whether this recommendation would affect
health inequities. The GDG unanimously agreed that this
option would probably be acceptable to key stakeholders; this
selection was driven by the assessment of the potential benefits
compared with the risks described above. Furthermore, the
majority of the GDG selected that providing MRI for acute
SCI patients is probably feasible to implement (probably no
¼ 1; uncertain ¼ 2; probably yes ¼ 15; yes ¼ 3, varies ¼ 1).
Potential barriers include costs and MRI availability, especially
in developing countries and smaller centers.
Considering all these factors, the GDG voted that the desir-
able consequences probably outweigh the undesirable conse-
quences in most settings (n ¼ 16/23); this led to the formation
of a weak recommendation that MRI be performed in adult
patients with acute SCI, when feasible, to improve clinical
decision making (n ¼ 15/20). In making this recommenda-
tion, we strongly considered that MRI can identify specific
features (including ongoing spinal cord compression, liga-
mentous injury, large disc herniations, and vertebral artery
injuries) that, if present, would alter clinical management and,
in turn, have a beneficial effect on outcomes. The GDG
agreed not to make a strong recommendation due to the lack
of direct evidence that MRI influences clinical decision
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making and the fact that a proportion of spine surgeons cur-
rently rely only on CT scans. It was also acknowledged that
the GDG included several individuals who have published
research in the area of MRI in acute SCI and that a strong
recommendation for MRI based solely on expert opinion
could be perceived as biased and not representative of the
range of expert opinions in the larger community.
Part 2. The Role of Baseline Magnetic Resonance
Imaging in Predicting Neurologic and Functional
Outcomes
Population Description: Patients with acute SCI
Key Question: Should baseline MRI (within 7 days of
injury) be performed in adult patients with acute spinal
cord injury to facilitate improved prognostication of neu-
rologic and functional outcomes?
Recommendation 2: We suggest that MRI should be per-
formed in adult patients in the acute period following
SCI, before or after surgical intervention, to improve
prediction of neurologic and functional outcome.
Quality of Evidence: Low
Strength of Recommendation: Weak
Evidence Summary
As previously described, a systematic review was performed to
inform the development of our clinical recommendations. Long-
itudinal studies that controlled for baseline clinical factors such
as neurologic status were considered for inclusion. Seven studies
were identified that evaluated MRI predictors of neurologic,
functional, patient-reported, and safety outcomes.5,6,16,27-30 Five
studies investigated the association between the presence of
intramedullary spinal cord hemorrhage (region of decreased
signal intensity surrounded by a thin rim of high signal
intensity on T2-weighted images in the acute period) and
neurologic outcomes.5,16,27-29 Two studies found no rela-
tionship,28,29 while 3 studies reported that the presence of
hemorrhage was predictive a worse neurologic recov-
ery.5,16,27 Longer rostro-caudal intramedullary hematoma
length was also associated with worse neurologic recovery
in 2 studies (moderate evidence).16,29
Two studies evaluated the relationship between maximum
canal compromise (MCC) and neurologic recovery.5,30 Of
these, one reported no association,5 and the other indicated that
a lower MCCwas associated with worse neurologic recovery.30
Maximum spinal cord compression (MSCC) was not predictive
of neurologic recovery across 3 studies.5,16,30
Based on 3 studies, MRI evidence of cord edema (a region
of high signal intensity on T2-weighted images) was not sig-
nificantly associated with neurologic outcomes.5,28,29 In con-
trast, a longer edema lesion length was predictive of worse
neurologic recovery in one study,27 but not another.16 In a third
study, edema lesion length was associated with neurologic
recovery in univariate but not multivariate analysis.29
Two studies reported no association between SCI lesion
(either hemorrhage, edema, or a combination of both) length
and neurologic recovery.5,30 Cord swelling (increased spinal
cord diameter) was marginally significantly associated with
worse neurologic outcomes in one study.5 Based on single
studies, there was no association between neurologic recovery
and soft-tissue injury,5 pre-injury stenosis,5 disc herniation,5
cord contusion,28 rostral point of edema,27 and smaller diame-
ter within swollen length of the cord.16
In summary, there is moderate evidence suggesting that a
longer hemorrhage length on MRI in the acute phase of injury
is predictive of a worse neurologic recovery, and that there is
no association between neurologic outcomes and cord edema,
MSCC, and SCI lesion length. There is low evidence indicating
that a lower MCC is associated with worse FIM (Functional
Independent Measure) scores, a longer SCI lesion length is
related to worse manual dexterity and dysesthetic pain, and
cord swelling is predictive of worse neurologic recovery.
Furthermore, based on low evidence, there is no association
between SCI lesion length and FIM scores, MSCC and func-
tional recovery, and MCC and manual dexterity or dysesthetic
pain. Finally, there is very low evidence suggesting that length
of cord swelling and the rostral point of edema are not associ-
ated with neurologic outcomes.
Rationale for Recommendation
The outcomes ranked as critical for decision making were
improved prediction of neurological and functional outcomes.
Seven studies discussed the predictive value of various MRI
factors using multivariate analysis that controlled for baseline
neurologic status. As presented above, the strength of evidence
ranged from very low to moderate; most findings had a serious
risk of imprecision and were inconsistent across studies (or had
unknown consistency if only one study was available). The
GDG unanimously agreed that the overall certainty of the evi-
dence was low.
The GDG acknowledged that there is possibly important
uncertainty or variability about how much stakeholders value
the main outcomes. Improved prognostication is potentially
valuable to patients and their families, while the benefit to other
stakeholders (clinicians and payers) is uncertain.
The anticipated desirable effects are improved prediction of
neurological and functional outcomes. The GDG unanimously
agreed that the anticipated desirable effects are probably not
large; however, knowledge of a patient’s likely outcome can help
appropriately manage expectations, determine the optimal treat-
ment pathway for patients, and improve allocation of resources.
The anticipated undesirable effects were the risks associated
with obtaining an MRI in the acute phase of SCI. These risks
depend on many factors such as concomitant injuries, neuro-
genic shock, autonomic dysreflexia, and pain and include (1)
keeping a patient supine for approximately 30 minutes, espe-
cially in critically ill patients with hemodynamic instability or
concomitant head/chest injuries; and (2) delaying the time to
spinal cord decompression. For the purpose of prediction,
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however, MRI can be performed in the postoperative time
period (potentially several days after injury) when most acute
medical issues are no longer present. The GDG unanimously
agreed that the undesirable effects of obtaining an MRI were
probably small; clinicians, however, must carefully assess
whether a patient can tolerate an MRI and if the benefit out-
weighs the risk. Based on the 2 previous responses, the GDG
was uncertain whether the desirable anticipated effects were
large relative to the anticipated undesirable effects.
The GDG unanimously agreed that the resources required to
implement MRI in the setting of acute SCI were not small. MRI
can be very costly and include both capital expenses (approx-
imately US$1-2 million) and operating costs (eg, facilities and
trained technicians). Unfortunately, there were no studies that
evaluated the cost-effectiveness of MRI; however, such a study
would likely require assumptions and methods that may limit
its validity/applicability across centers and countries. As a
result, the GDG agreed that it is uncertain whether the incre-
mental cost of MRI in an acute SCI setting is small relative to
the net benefits.
The GDG unanimously agreed that a recommendation for
MRI would probably reduce health inequities if policy makers
fund initiatives to ensure patients with SCI have better access to
MRI. The GDG also agreed that this option would probably be
acceptable to key stakeholders although there is some uncer-
tainty given the lack of evidence on the cost-effectiveness of
this option. Furthermore, the majority of the GDG felt that
providing MRI for acute SCI patients is probably feasible to
implement. Potential barriers include costs and MRI availabil-
ity, especially in developing countries and smaller centers.
Considering these factors, the entire GDG voted that the
desirable consequences probably outweigh the undesirable
consequences in most settings; this led to the formation of a
weak recommendation that MRI be performed in adult patients
with acute SCI, before or after surgical intervention, to improve
prediction of neurologic outcomes
Evidence Gaps and Future Research
Recommendations
Despite publication of numerous studies investigating the use
of MRI in acute SCI, no studies directly link the application of
MRI to changes in clinical decision making; only one low-
quality study indirectly evaluated the association between
obtaining an MRI and changes in neurological outcome. This
study, however, primarily focused on the impact of early sur-
gical decompression rather than MRI, which were linked
together in a protocolized treatment algorithm. Furthermore,
no studies compared decision making based on MRI with deci-
sion making based on other imaging modalities or no MRI.
Future prospective studies are needed to better identify how
pretreatment MRI in acute SCI alters clinical decision making,
such as the need, timing, type, and approach of surgery, and
ultimately affects neurological and functional outcomes. Such
studies must follow strict protocols and document decision
making and outcome assessment. Moreover, studies are also
needed that compare decision making based on MRI with other
imaging modalities. Further research is also needed on the
utility of MRI for later stages of care in SCI, such as assessing
the quality of spinal cord decompression following surgery,
and for monitoring the chronic phase for development of post-
traumatic syringomyelia.
The 7 studies that investigated the association between MRI
characteristics and outcomes following acute SCI used differ-
ent MRI features and outcome measures, limiting our ability to
synthesize results. Future methodologically sound studies with
sufficient sample sizes are warranted to better characterize the
relationship between MRI factors such as hemorrhage, edema,
and cord compression and standard neurologic outcomes such
as AIS (American Spinal Injury Association Impairment Scale)
and ISNCSCI (International Standards for Neurological
Classification of Spinal Cord Injury) motor score. Recently,
additional studies have been published that were not included
in our systematic review but should be considered for future
updates of these guidelines; for example, a single study by
Talbott et al31 introduced a novel “Brain and Spinal Injury
Score” based on axial T2-weighted images to assess the sever-
ity of acute SCI, whereas another study by Haefeli et al32
employed a multivariate approach using nonlinear principle
analysis to examine the prognostic value of several MRI char-
acteristics. Future prospective longitudinal studies are needed
to accurately determine the predictive value of various MRI
factors, while adjusting for baseline neurological status as this
is a well-established prognostic factor.
No evidence was identified that evaluated the utility of DTI
for prognostication in acute SCI. Investigation into DTI and
other emerging MRI techniques, such as magnetization transfer
(MT), MR spectroscopy (MRS), myelin water fraction (MWF),
and functional MRI (fMRI) should be pursued, as these tech-
niques can characterize specific aspects of tissue microstruc-
ture and function that may better correlate with outcomes
compared to conventional MRI.33-35 These techniques are rap-
idly evolving and becoming increasingly available, but their
utility for prognostication in acute SCI has yet to be
established.
Finally, the relationship between cost and clinical utility of
MRI has not been established in acute SCI. Future research
that characterizes a positive cost-effectiveness ratio would
help promote adoption and standardization of MRI into clin-
ical protocols.
Implementation Considerations
It is expected that this guideline will influence clinical practice
and facilitate evidence-based decision making. Dissemination
of the knowledge from this guideline is of critical importance
and will be accomplished at multiple levels:
1. Presentation at international spine surgery, critical care,
neurology, anesthesiology, and vascular medicine
conferences
2. Scientific and educational courses in symposium format
Fehlings et al 227S
3. Webinar dissemination of information to a broad audi-
ence in an interactive format
4. Publication of a focus issue in a peer-reviewed journal
5. Submission to the National Guideline Clearinghouse
6. AOSpine International Spinal Cord Injury Knowledge
Forum
Potential barriers to implementation include the following:
1. The availability of MRI: Each spine trauma center
would require timely access to MRI so that decision
making based on MRI findings would not prevent
timely surgical decompression. This does not necessa-
rily require 24-hour per day MRI availability, which
can be costly, but requires availability within a time-
frame that allows for early surgical decompression
(24 hours of injury).
2. Clinical uptake by physicians: This guideline is based on
very low to low level evidence and expert opinion, which
may not be sufficient to drive policy changes. Thus, the
decision to obtain an MRI in the acute phase of SCI will
likely remain in the hands of individual surgeons. It may
be difficult to change the beliefs and/or practices of these
individuals without stronger evidence.
3. The recommendation to obtain MRI in patients with
acute SCI does not apply to a small subset of patients,
including those deemed too unstable to tolerate a
supine MRI.
Internal Appraisal and External Review
of This Guideline
Vice-Chairs of the GDG conducted an internal appraisal of
the final guideline using Appraisal of Guidelines for Research
& Evaluation II (AGREE II) standards.36 A multidisciplinary
group of stakeholders, including patients, were invited to
externally review the final draft prior to publication. Addi-
tional details of these processes and a summary of conflict of
interests for external reviewers are found in the accompany-
ing methods paper.
Plans for Updating
The guidelines will be reviewed by the primary sponsor and the
Vice-Chairs at 3 years to a maximum of 5 years following
publication. The guideline will be updated when new evidence
suggests the need to modify our recommendations. An earlier
update will be considered if there are changes in (1) the evi-
dence related to harms and benefits; (2) outcomes that would be
considered important for decision making; (3) ranking of
current critical and important outcomes; and (4) available
interventions and resources.37
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